MD Financial Management’s Celanese CE Stock Holding History

MD Financial Management’s Portfolio CE Stock Details CE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$2.38M	Sell	14,157 -1,595	-10%	-$260K	0.06%	169
2021 Q3	$2.37M	Buy	15,752 +954	+6%	+$147K	0.06%	141
2021 Q2	$2.24M	Buy	+14,798	New	+$2.35M	0.06%	153

Other funds holding CE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MD Financial Management's CE Position: Q4 2021 in Review

MD Financial Management reduced its Celanese (CE) stake by 10% in Q4 2021, selling an estimated $260K and leaving 14,157 shares worth $2.38M. The position accounts for 0.06% of the portfolio, ranked #169.

MD Financial Management first reported a position in CE in Q2 2021 and has held it in 3 quarters since. 712 funds tracked by Wall St. Rank hold CE as of Q4 2021.

MD Financial Management held 14,157 shares of Celanese worth $2.38M as of Q4 2021.
MD Financial Management sold 1,595 Celanese shares in Q4 2021, an estimated $260K.
Celanese made up 0.06% of MD Financial Management's portfolio in Q4 2021, its #169 holding.
MD Financial Management first reported a position in Celanese in Q2 2021 and has held it in 3 quarters since.
712 funds tracked by Wall St. Rank held Celanese as of Q4 2021.

Based on MD Financial Management's 13F filing for Q4 2021, filed 14 Feb 2022.